1. Home
  2. ETS vs GNLX Comparison

ETS vs GNLX Comparison

Compare ETS & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ETS

Elite Express Holding Inc.

N/A

Current Price

$1.78

Market Cap

107.4M

Sector

Industrials

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

N/A

Current Price

$2.00

Market Cap

110.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ETS
GNLX
Founded
2020
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.4M
110.4M
IPO Year
2025
2022

Fundamental Metrics

Financial Performance
Metric
ETS
GNLX
Price
$1.78
$2.00
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $18.83
AVG Volume (30 Days)
54.8K
★ 421.9K
Earning Date
10-14-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9.47
EPS
★ N/A
N/A
Revenue
★ $2,665,948.00
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 21.57
N/A
52 Week Low
$0.39
$1.86
52 Week High
$2.75
$8.54

Technical Indicators

Market Signals
Indicator
ETS
GNLX
Relative Strength Index (RSI) 49.29 37.48
Support Level $0.56 N/A
Resistance Level $1.88 $2.78
Average True Range (ATR) 0.37 0.23
MACD -0.05 -0.02
Stochastic Oscillator 44.83 18.61

Price Performance

Historical Comparison
ETS
GNLX

About ETS Elite Express Holding Inc.

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: